Advisory Council on the Misuse of Drugs (UK)·AI score58
UK advisory council advises ketamine stays class B and calls for more support on harms
ACMD announces decision on the classification of ketamine
AI summary
The Advisory Council on the Misuse of Drugs has advised the UK government that ketamine should remain a class B controlled substance, after the government asked it in January 2025 to review the prevalence and harms of ketamine misuse.
Key facts
- Kind of item
- Regulator decisions
- Compound
- Ketamine and esketamine
- Jurisdiction
- United Kingdom
- Source
- Advisory Council on the Misuse of Drugs (UK) (gov.uk)
- Published
- Original
- Read it at gov.uk
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Advisory Council on the Misuse of Drugs (UK) · gov.uk
Connected to
- Kind of item
- Regulator decisions
- Compound
- Ketamine and esketamine
- Jurisdiction
- United Kingdom
- Theme
- Harm reduction